Reneo Pharmaceuticals Inc (RPHM)
1.72
+0.06
(+3.61%)
USD |
NASDAQ |
May 17, 16:00
1.70
-0.02
(-1.16%)
After-Hours: 20:00
Reneo Pharmaceuticals Accounts Payable (Quarterly): 0.676M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.676M |
December 31, 2023 | 8.717M |
September 30, 2023 | 2.473M |
June 30, 2023 | 1.828M |
March 31, 2023 | 1.802M |
December 31, 2022 | 1.893M |
September 30, 2022 | 2.189M |
Date | Value |
---|---|
June 30, 2022 | 1.56M |
March 31, 2022 | 1.566M |
December 31, 2021 | 2.022M |
September 30, 2021 | 1.271M |
June 30, 2021 | 0.434M |
March 31, 2021 | 0.556M |
December 31, 2020 | 0.908M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.434M
Minimum
Jun 2021
8.717M
Maximum
Dec 2023
1.992M
Average
1.684M
Median
Accounts Payable (Quarterly) Benchmarks
Mirum Pharmaceuticals Inc | 15.98M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 1.594M |
iBio Inc | 1.859M |
Theriva Biologics Inc | 0.571M |